Drug Profile
Vascular endothelial growth factor-2 monoclonal antibody
Latest Information Update: 25 Oct 2005
Price :
$50
*
At a glance
- Originator Human Genome Sciences
- Class Monoclonal antibodies
- Mechanism of Action Vascular endothelial growth factor receptor-2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 25 Oct 2005 No development reported - Preclinical for Cancer in USA (unspecified route)
- 06 May 2002 Preclinical trials in Cancer in USA (unspecified route)